Live
- Man held for siphoning Rs 8.14 cr in trading scam
- Don’t pressurise students for fees
- Almonds are a key to faster muscle recovery after exercise: Study
- No govt faced so much criticism than Revanth-led Cong in 11 months: Kavitha
- Balineni signed SECI agreement, says Chevireddy
- Infant kidnapped from Niloufer Hospital rescued, cops arrest 3
- Sunny Leone reflects on challenges and preparations for ‘Shero’
- Hyderabad Saree Festival 2024 kicks off in a grand manner
- Speed up Veligonda project works, CPM urges govt
- 10 career opportunities with a public policy degree
Covaxin neutralises UK variant of Covid: Study
Second dose of covaxin to be distributed from today in the state
Covaxin, the Covid vaccine developed by Bharat Biotech, effectively neutralizes UK variants of SARS-CoV-2 reducing the possibility of mutant virus escape, finds a study.
Hyderabad: Covaxin, the Covid vaccine developed by Bharat Biotech, effectively neutralizes UK variants of SARS-CoV-2 reducing the possibility of mutant virus escape, finds a study.
According to a research paper carried by bioRxiv, the preprint server for biology, the study has dispelled the uncertainty of possible neutralisation escape.
A group of researchers from Indian Council of Medical Research(ICMR), National Institute of Virology, Pune and Bharat Biotech performed the plaque reduction neutralization test (PRNT50) using sera collected from the 26 recipients of BBV152/Covaxin against hCoV-19/India/20203522 (UK-variant) and hCoV27 19/India/2020Q111 (heterologous strain).
